Zavodnick Todd Erik 4
4 · Revance Therapeutics, Inc. · Filed Oct 17, 2018
Insider Transaction Report
Form 4
Zavodnick Todd Erik
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2018-10-15$23.94/sh−7,093$169,806→ 96,407 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered by Mr. Zavodnick to the Issuer on October 15, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2017 Restricted Stock Award ("RSA") for 95,000 shares. The RSA vests in four equal annual installments from October 15, 2017, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date.